✦ LIBER ✦

PReS-FINAL-2311: Rituximab in paediatric ANCA-associated vasculitis

✍ Scribed by Mestrallet, G; Faye, A; Quartier, P; Ranchin, B; Cochat, P; Belot, A

Book ID: 121589739
Publisher: BioMed Central
Year: 2013
Tongue: English
Weight: 95 KB
Volume: 11
Category: Article
ISSN: 1546-0096
DOI: 10.1186/1546-0096-11-S2-P301

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rituximab beneficial in ANCA-associated

Rituximab beneficial in ANCA-associated vasculitis

📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Rituximab in ANCA-Associated Vasculitis:

Rituximab in ANCA-Associated Vasculitis: Fad or Fact?

✍ Fervenza, Fernando C. 📂 Article 📅 2011 🏛 S. Karger AG 🌐 English ⚖ 199 KB

Rituximab versus Cyclophosphamide in ANC

Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis

✍ Jones, Rachel B.; Cohen Tervaert, Jan Willem; Hauser, Thomas; Luqmani, Raashid; 📂 Article 📅 2010 🏛 Massachusetts Medical Society 🌐 English ⚖ 408 KB

Rituximab versus Cyclophosphamide in ANC

Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis

✍ Jones, Rachel B.; Cohen Tervaert, Jan Willem; Hauser, Thomas; Luqmani, Raashid; 📂 Article 📅 2010 🏛 Massachusetts Medical Society 🌐 English ⚖ 408 KB

## Background: Cyclophosphamide induction regimens for antineutrophil cytoplasmic antibody (anca)-associated vasculitis are effective in 70 to 90% of patients, but they are associated with high rates of death and adverse events. treatment with rituximab has led to remission rates of 80 to 90% among

Rituximab and B-Cell Return in ANCA-Asso

Rituximab and B-Cell Return in ANCA-Associated Vasculitis

✍ Wilde, Benjamin; Witzke, Oliver; Cohen Tervaert, Jan Willem 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Acquired Hemophilia in Association With

Acquired Hemophilia in Association With ANCA-Associated Vasculitis: Response to Rituximab

✍ Menna R. Clatworthy; David R.W. Jayne 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 135 KB